Asiedu D K, Frøyland L, Vaagenes H, Lie O, Demoz A, Berge R K
Department of Clinical Biology, University of Bergen, Norway.
Biochim Biophys Acta. 1996 Apr 19;1300(2):86-96. doi: 10.1016/0005-2760(95)00235-9.
Administration of tetradecylthioacetic acid (a 3-thia fatty acid) increases mitochondrial and peroxisomal beta-oxidative capacity and carnitine palmitoyltransferase activity, but reduces free fatty acid and triacylglycerol levels in plasma compared to palmitic acid-treated rats and controls. The decrease in plasma triacylglycerol was accompanied by a reduction (56%) in VLDL-triacylglycerol. Prolonged supplementation of tetradecylthioacetic acid caused a significant increase in lipogenic enzyme activities (ATP-citrate lyase and acetyl-CoA carboxylase) and diacylglycerol acyltansferase, but did not affect phosphatidate phosphohydrolase. Plasma cholesterol, LDL- and HDL-cholesterol levels were reduced. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity was, however, stimulated in 3-thia fatty acid-treated rats compared to controls. In addition. the mRNAs of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and LDL-receptor were increased. Tetradecylthioacetic acid administration affected the fatty acid composition in plasma and liver by increasing the amount of monoenes, especially 18:1(n-9), mostly at the expense of omega-3 fatty acids. Compared to liver a large amount of tetradecylthioacetic acid accumulated in the heart, and this accumulation was accompanied by an increase in omega-3 fatty acids, particularly 22:6(n-3) and a decrease in omega-6 fatty acids, mainly 20:4(n-6). The results show that the hypolipidemic effect of tetradecylthioacetic acid is sustained after prolonged administration and may, at least in part, be due to increased fatty acid oxidation and upregulated LDL-receptor gene expression. The increase in lipogenic enzyme activities as well as increased 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity, may be compensatory mechanisms to maintain cellular integrity. Decreased level of 20:4(n-6) combined with increased omega-3/omega-6 ratio in cardiac tissue after tetradecylthioacetic acid treatment may have influence on membrane dynamics and function.
与棕榈酸处理的大鼠和对照组相比,给予十四烷基硫代乙酸(一种3-硫代脂肪酸)可增加线粒体和过氧化物酶体的β-氧化能力以及肉碱棕榈酰转移酶活性,但可降低血浆中的游离脂肪酸和三酰甘油水平。血浆三酰甘油的降低伴随着极低密度脂蛋白-三酰甘油减少(56%)。长期补充十四烷基硫代乙酸可导致生脂酶活性(ATP-柠檬酸裂解酶和乙酰辅酶A羧化酶)和二酰甘油酰基转移酶显著增加,但不影响磷脂酸磷酸水解酶。血浆胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇水平降低。然而,与对照组相比,3-硫代脂肪酸处理的大鼠中3-羟基-3-甲基戊二酰辅酶A还原酶活性受到刺激。此外,3-羟基-3-甲基戊二酰辅酶A还原酶和低密度脂蛋白受体的mRNA增加。给予十四烷基硫代乙酸会影响血浆和肝脏中的脂肪酸组成,通过增加单烯酸的量,尤其是18:1(n-9),主要是以ω-3脂肪酸为代价。与肝脏相比,大量十四烷基硫代乙酸在心脏中蓄积,这种蓄积伴随着ω-3脂肪酸增加,尤其是22:6(n-3),以及ω-6脂肪酸减少,主要是20:4(n-6)。结果表明,长期给药后十四烷基硫代乙酸的降血脂作用持续存在,且可能至少部分归因于脂肪酸氧化增加和低密度脂蛋白受体基因表达上调。生脂酶活性增加以及3-羟基-3-甲基戊二酰辅酶A还原酶活性增加可能是维持细胞完整性的代偿机制。十四烷基硫代乙酸处理后心脏组织中20:4(n-6)水平降低以及ω-3/ω-6比值增加可能会影响膜的动力学和功能。